GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc, (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease ...
HL Mando has patented a composition for intravenous injection containing beta-cyclodextrin molecules with hydroxypropyl groups, suitable for treating Niemann-Pick disease Type C. The composition is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results